U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07272629) titled 'A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.' on Nov. 26.
Brief Summary: This is a Phase 1, multicenter, randomized, double-blind, double-dummy, single dose, placebo- and positive-controlled, 4-sequence, 4-treatment, 4-period crossover study.
Study Start Date: Dec. 03
Study Type: INTERVENTIONAL
Condition:
Cardiac Repolarization
Healthy Volunteers
Intervention:
DRUG: Balinatunfib
Pharmaceutical form: Tablet Route of administration: Oral
DRUG: Moxifloxacin
Pharmaceutical form: Tablet Route of administration: Oral
DRUG: Placebo
Pharmaceutical form...